ContextVision – Invitation to Annual General Meeting 2022

STOCKHOLM – March 31, 2022 – ContextVision hereby invites shareholders to the Annual General Meeting on May 4, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact: for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail:
Read More

ContextVision presents Annual Report 2021

STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: For inquiries, please contact CFO Markus Hökerberg E-mail: ### About ContextVision ContextVision is a medical technology software company […]
Read More

ContextVision shows strong momentum in Q4, leading to record sales for the year

STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK (94.7), which is the highest revenue in the history of the company. After a slow […]
Read More

ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO

STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business. Previous leaders at ContextVision will assume new roles, including the appointment of Ola Lindblad as […]
Read More

ContextVision – Information regarding dividend and reverse share split in Inify Laboratories

ContextVision AB (“ContextVision” or the “Company”) will, in accordance with the press release published on 2 February 2022, distribute all shares in its wholly-owned subsidiary INIFY Laboratories AB (“INIFY”) to the shareholders of ContextVision. The shares in INIFY are expected to be delivered to shareholders who have their shares registered at Euroclear Sweden AB around […]
Read More

ContextVision announces resolution regarding record date for dividend

Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to the shareholders of the Company. The board of directors has determined the record date for […]
Read More

ContextVision – new CFO appointed

Stockholm, January 12th, 2022 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Markus Hökerberg as an interim Chief Financial Officer, effective 25th of January. He succeeds Ann-Charlotte Linderoth, who will take on the same role at Inify Laboratories, a spinoff from ContextVision. Mrs Linderoth will remain within the […]
Read More